Mara Aspinall is a healthcare industry leader and pioneer committed to active civic involvement. She is Managing Director and Co-Founder of BlueStone Venture Partners. Aspinall also heads Health Catalysts Group, a consulting firm for HIT and Diagnostics, publishing the popular Health Catalysts Diagnostics Year in Review. She is a member of the Board of Directors of Abcam plc, Allscripts, Castle Biosciences, OraSure and Blue Cross Blue Shield Arizona. Aspinall is an advisor to The Rockefeller Foundation on COVID Diagnostics. Aspinall is passionate about education on diagnostics, genomics and personalized medicine. To that end, Mara co-founded the School of Biomedical Diagnostics at Arizona State University, the first school dedicated to Diagnostics as an independent discipline. Previously, Aspinall served as President and CEO of Roche Tissue Diagnostics; President of Genzyme Genetics and Genzyme Pharmaceuticals; on the Health and Human Services Secretary’s Advisory Council on Genetics, Health & Society (SACGHS); was named Arizona Biosciences Leader of the Year by the Arizona Bio Association and one of “100 Most Inspiring People in Life Sciences” by PharmaVOICE and one of Women Inc’s Most Influential Corporate Board Directors. Ms. Aspinall holds an MBA from Harvard Business School and a BA from Tufts University.